We evaluated 118 women presenting to a College Health Service with dysuria. For each patient, data on GU symptoms, medical, and sexual history were obtained; a physical and pelvic exam ...

Though a systematic review did not find any short-term or long-term benefits from energy-based therapies, it also did not ...

A Q+A with Jill Osborne, Founder & CEO of the Interstitial Cystitis Network The following is from an interview with Jill ...

Ketosis is a natural metabolic state that is generally safe, but some aspects of it may be dangerous. Popularized by the keto ...

Though conducted at a single clinic, study results match previous ones finding undertreatment for women with GSM.

THE NUMBER of cases of Mpox in Ireland has been revealed after the World Health Organisation declared it a public health ...

Johnson & Johnson (NYSE:JNJ) announced today additional results from the pivotal Phase 2b SunRISe-1 study, supporting the safety and efficacy profile of investigational TAR-200 for the treatment of ...

Given as neoadjuvant treatment, TAR-200 plus cetrelimab generated responses in patients with muscle-invasive bladder cancer.

Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...